Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Background: To evaluate the diagnostic performance of radiomic signatures extracted from contrast-enhanced magnetic resonance imaging (CE-MRI) for the assessment of breast cancer receptor status and molecular subtypes.Methods: One hundred and forty-three patients with biopsy-proven breast cancer who...
| Publicado en: | Breast Cancer Research Vol. 21; no. 1 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
BioMed Central
9/12/2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |